Mark Andersen

Mark Andersen

No open positions remaining
55 year
Health Technology
Commercial Services
Consumer Services

Profile

Mark Andersen worked as an Investments Director-Pension Plan at Eli Lilly & Co. from 2004 to 2015.
He then served as Vice President-Finance & Controller at MiMedx, Inc. in 2015 and 2016.
Mark also worked as an Auditor at Deloitte Development LLC from 1998 to 1999 and at KPMG US LLP from 1996 to 1998.
He held the position of Chief Financial Officer & VP-Administration at Indiana Biosciences Research Institute from 2016 to 2022.
Currently, Mark is the Chief Financial Officer at FibroBiologics, Inc. since 2022.
Mr. Andersen completed his undergraduate and graduate degrees at Southern Utah University and holds an MBA from Stephen M.
Ross School of Business.

Former positions of Mark Andersen

CompaniesPositionEnd
FIBROBIOLOGICS, INC. Director of Finance/CFO 28/10/2024
Director of Finance/CFO 01/05/2022
Director of Finance/CFO 01/02/2016
ELI LILLY AND COMPANY Corporate Officer/Principal 01/08/2015
Comptroller/Controller/Auditor 01/01/1999
See the detail of Mark Andersen's experience

Training of Mark Andersen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

83

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!